FLI1 and neoplasm: Our results implied that low-methylation-induced or ncRNA-mediated downregulation of FLI1 was correlated with poor prognosis, and that FLI1 might regulate the tumor immune microenvironment, primarily by targeting immune cells interactions, including myeloid cells and T cells, via cell-type-specific target genes in BRCA.